Citation Impact
Citing Papers
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
2010
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 Standout
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 StandoutNobel
Induction of the Cytoprotective Enzyme Heme Oxygenase-1 by Statins Is Enhanced in Vascular Endothelium Exposed to Laminar Shear Stress and Impaired by Disturbed Flow
2009
Head and neck squamous cell carcinoma
2020 Standout
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F
2011
PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data
2014
Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists
2017
The molecular hallmarks of epigenetic control
2016 Standout
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
A view on drug resistance in cancer
2019 StandoutNature
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
2012 Standout
Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma
2013
Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients
2011
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
2012
Ovarian cancer
2014 Standout
Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure
2012
Potential application ofIDH1andIDH2mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis
2012
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
SWI/SNF nucleosome remodellers and cancer
2011 Standout
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository
2013
The Cancer Genome Atlas Pan-Cancer analysis project
2013 Standout
IDH mutations in acute myeloid leukemia
2012
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Dynamic RNA Modifications in Gene Expression Regulation
2017 Standout
Global cancer statistics
2011 Standout
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
Non-viral vectors for gene-based therapy
2014 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
2017 Standout
Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
2019 Standout
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
2015
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Driver mutations of cancer epigenomes
2014
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
2010 Standout
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
2011
RNA N6-methyladenosine modification in cancers: current status and perspectives
2018
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Primary brain tumours in adults
2012 Standout
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
2011
Dock-family exchange factors in cell migration and disease
2014
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study
2016
Use of mutation profiles to refine the classification of endometrial carcinomas
2012
Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia
2012
Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis
2009
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
miR-34 – a microRNA replacement therapy is headed to the clinic
2012
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
2010
Discovery and saturation analysis of cancer genes across 21 tumour types
2014 StandoutNature
The myocardial JAK/STAT pathway: From protection to failure
2008
Ovarian Cancer Development and Metastasis
2010
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
The Dualistic Model of Ovarian Carcinogenesis
2016
Primary CNS Lymphoma in Immunocompetent Patients
2009
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Acute Myeloid Leukemia
2015 Standout
Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
2013 Standout
Ovarian cancer statistics, 2018
2018 Standout
Incidence trends of human papillomavirus‐related head and neck cancer in Taiwan, 1995–2009
2014
Worldwide burden of cancer attributable to HPV by site, country and HPV type
2017 Standout
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia
2013
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Cancer Genome Landscapes
2013 StandoutScience
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade
2016
IDH mutations in Primary Myelofibrosis Predict Leukemic Transformation and Shortened Survival: Clinical Evidence for Leukemogenic Collaboration with JAK2V617F
2011
Understanding TERT Promoter Mutations: A Common Path to Immortality
2016
Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers
2013
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Mineralocorticoid Receptor and Cardiovascular Disease
2018
Works of Kuan‐Ting Kuo being referenced
Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas
2009
DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma
2010
The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma—molecular basis and predicting favorable outcome
2008
Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation
2014
Increased Expression of Mineralocorticoid Receptor in Human Atrial Fibrillation and a Cellular Model of Atrial Fibrillation
2010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
2010
Long-term Follow-up of Gastrectomized Patients With Mucosa-associated Lymphoid Tissue Lymphoma
2008
Somatic Mutations of PPP2R1A in Ovarian and Uterine Carcinomas
2011
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
2012
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
2009
2014
Loss of ARID1A Expression Correlates With Stages of Tumor Progression in Uterine Endometrioid Carcinoma
2013
Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.
2006
Angiotensin II Activates Signal Transducer and Activators of Transcription 3 via Rac1 in Atrial Myocytes and Fibroblasts
2008
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID 1A expression
2014